Clinical Trial

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF)

Study acronym: SCORE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to assess continued safety and efficacy of the SeQuent® SCB. The product under investigation will be used in routine clinical practice according to the latest European Society of Cardiology (ESC) guidelines and according to the Instructions for Use (IFU). Those data that are obtained in routine clinical use will be documented in the Case Report Form (CRF).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-07-10; most recent amendment 2026-07-15.
Status change: Recruiting → Active, Not Recruiting 2025-01-14
Status change: Not Yet Recruiting → Recruiting 2021-05-17
Trial Details
NCT Number NCT04470934
Lead Sponsor B. Braun Melsungen AG
Conditions Coronary Artery Disease, Myocardial Ischaemia
Enrollment 1,302 participants
Start Date 2021-04-30
Primary Completion 2026-03-03 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-16